查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1871934

全球按需即时检测盒式实验室市场：预测至 2032 年—按测试类型、技术、应用、最终用户和地区分類的分析

On-Demand Point-of-Care Lab-in-a-Box Market Forecasts to 2032 - Global Analysis By Test Type, Technology, Application, End User, and By Geography.
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球按需 POC 盒式实验室市场预计将在 2025 年达到 478 亿美元，并在 2032 年达到 713 亿美元，预测期内复合年增长率为 5.8%。

按需即时检测（POC​​）一体化实验室系统是一种便携式自主型诊断平台，可在患者所在地直接提供快速临床检测和结果。这些设备整合了微型分析仪器、流体技术和数位连接功能，使临床医生无需依赖中央检查室即可进行血液、尿液或拭子检测。透过在护理点提供全面及时的诊断，该解决方案可加快决策速度，改善偏远地区的医疗服务，并支援分散式医疗保健。

世界卫生组织表示，小型自动化检测系统正在偏远诊所部署，可在 30 分钟内完成疟疾和爱滋病毒等疾病的诊断测试，从而大大缩短开始治疗的时间。

对分散式诊断的需求日益增长

对分散式诊断日益增长的需求源于偏远和医疗资源匮乏地区对快速便捷检测的需求。按需提供的「盒式实验室」平台无需集中式检查室即可实现照护现场(POC)，从而缩短检测结果的周转时间，并优化临床决策。慢性病盛行率的上升、人口老化以及个人化医疗的进展进一步推动了这一趋势。医疗系统正在采用携带式诊断解决方案，以减轻医院的负担，并提升居家医疗和急诊等医疗服务水准。

小型分析仪高成本

儘管小型分析仪效用，但由于采用了先进的微流体集成技术、专用试剂和小型化硬件，用于“盒式实验室”系统的小型分析仪价格仍然昂贵。这些成本限制了它们在资源匮乏地区和小规模诊所的普及。此外，维护、校准和耗材也会增加营运成本。缺乏规模经济和有限的报销机制进一步限制了市场渗透。价格敏感的买家往往会等待更具成本效益的替代方案或补贴，在临床需求强劲的情况下，减缓了整体市场成长。

与远端医疗平台集成

实验室一体化诊断​​和远端医疗平台的整合带来了变革性的机会。即时数据共用、远端监测和虚拟会诊能够改善诊断流程并提升病人参与。这种整合使临床医生能够即时解读结果并远端启动治疗，尤其是在偏远和偏远地区。这种协同效应有助于慢性病管理、术后照护和感染疾病监测。随着远端医疗在全球的快速普及，嵌入虚拟医疗生态系统的诊断技术将推动创新并扩大市场覆盖范围。

严格的规章制度和精确度标准

由于其对临床的重大影响，实验室一体化解决方案面临严格的监管审查。确保分析的准确性、可重复性以及符合ISO和FDA标准极具挑战性，尤其对于多重检测和新型平台而言更是如此。监管审批的延迟、复杂的核准流程以及上市后监测要求都会延长产品上市时间并增加成本。任何性能偏差都可能导致产品召回和诉讼，从而损害品牌声誉。这些障碍阻碍了新进入者，并要求企业在检验、文件记录和品质保证系统方面进行大量投资。

新冠疫情的影响：

新冠疫情显着加速了即时检测（POC​​）一体化诊断​​技术的应用，尤其是在快速分子检测和抗原检测方面。疫情凸显了对分散式、扩充性和非接触式诊断解决方案的需求。各国政府和医疗机构已投入大量资金携带式平台，以控制疫情传播并缓解检查室压力。然而，随着疫情后世界逐渐恢復正常，紧急资金投入减少，优先事项也正在转变。儘管对呼吸道疾病和感染疾病检测的需求依然旺盛，但供应商必须将业务重心转向更广泛的慢性病和预防保健应用领域。

预计在预测期内，分子诊断领域将占据最大的市场份额。

由于分子诊断具有高灵敏度和特异性，且在感染疾病、肿瘤和基因筛检领域应用广泛，预计在预测期内，分子诊断领域将占据最大的市场份额。盒式实验室平台正越来越多地整合PCR、等温扩增和定序技术，用于快速病原体检测和突变分析。该领域受益于对早期诊断、个人化医疗和疫情管理日益增长的需求。与数位健康工具的整合以及小型化设计使其成为即时检测（POC​​）部署的理想选择，从而巩固了其市场主导地位。

预计在预测期内，微流体领域将实现最高的复合年增长率。

预计在预测期内，微流体领域将实现最高成长率，这主要得益于其能够将复杂的实验室流程微型化并整合到携带式晶片中。这些系统能够进行多重检测，减少试剂用量，并快速提供检测结果。晶片设计、材料科学和流体学领域的创新正在推动微流控技术在血液学、免疫检测和分子诊断等领域的应用不断拓展。随着市场对紧凑、自动化和用户友好型平台的需求日益增长，微流体技术将成为下一代「盒式实验室」解决方案的基础，吸引投资并促进技术的快速发展。

占比最大的地区：

亚太地区预计将在预测期内占据最大的市场份额，这主要得益于其庞大的人口基数、不断增长的医疗保健支出以及对分散式诊断日益增长的需求。中国、印度和日本等国家正在投资建造携带式诊断基础设施，以解决医疗保健资源分配不均和农村地区感染疾病负担过重的问题。政府的积极倡议、不断扩展的远端医疗网络以及本地化的製造能力都在推动市场成长。该地区多样化的医疗保健需求和快速的都市化使其成为「盒式实验室」应用的理想目标区域。

预计年复合成长率最高的地区：

在预测期内，北美预计将实现最高的复合年增长率，这主要得益于其先进的医疗基础设施、强大的研发投入以及对创新诊断技术的早期应用。美国在远距远端医疗整合、监管核准以及即时检测（POC​​）技术的报销框架方面处于主导地位。对居家检测、慢性病管理和个人化医疗日益增长的需求正在推动市场扩张。策略合作、创业投资和有利的政策支援将进一步促进成长，使北美成为「盒式实验室」解决方案的领先创新中心。

免费客製化服务资讯：

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
  • 分析材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球按需即时检测盒式实验室市场（按测试类型划分）

  • 分子诊断
  • 免疫检测测定
  • 血液检查
  • 化学物质小组
  • 微生物和病原体检测
  • 基因组和蛋白质体检测

6. 全球按需POC盒式实验室市场（依技术划分）

  • 微流体
  • 实验室晶片
  • 基于人工智慧的诊断
  • 可携式PCR系统
  • 基于生物感测器的检测
  • 云端连线分析

7. 全球按需 POC 盒式实验室市场（按应用划分）

  • 传染病检查
  • 慢性病管理
  • 药物检测
  • 基因检测
  • 癌症检测
  • 健康与预防保健

8. 全球按需POC盒式实验室市场（依最终用户划分）

  • 医院和诊所
  • 门诊治疗中心
  • 居家医疗提供者
  • 诊断检查室
  • 军事和野战部队
  • 研究所

9. 全球按需POC盒式实验室市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品上市
  • 业务拓展
  • 其他关键策略

第十一章：公司简介

  • Abbott Laboratories
  • Roche Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Becton Dickinson
  • Thermo Fisher Scientific
  • QuidelOrtho
  • PerkinElmer
  • Mesa Biotech
  • Cue Health
  • LumiraDx
  • Bio-Rad Laboratories
  • BioMerieux
  • Cardinal Health
  • Hologic
  • BD Veritor
  • OraSure Technologies
Product Code: SMRC32304

According to Stratistics MRC, the Global On-Demand Point-of-Care Lab-in-a-Box Market is accounted for $47.8 billion in 2025 and is expected to reach $71.3 billion by 2032 growing at a CAGR of 5.8% during the forecast period. On-Demand Point-of-Care Lab-in-a-Box systems are portable, self-contained diagnostic platforms that provide rapid clinical testing and results directly at the patient location. Incorporating miniaturized analytical instruments, fluidics, and digital connectivity, these devices allow clinicians to perform blood, urine, or swab tests without centralized lab infrastructure. The solution accelerates decision-making, improves access in remote areas, and supports decentralized healthcare by offering comprehensive, timely diagnostics at the point of care.

According to the WHO, compact, automated lab systems are being deployed in remote clinics to perform diagnostic tests like malaria or HIV in under 30 minutes, drastically reducing time-to-treatment.

Market Dynamics:

Driver:

Growing need for decentralized diagnostics

The rising demand for decentralized diagnostics is driven by the need for rapid, accessible testing in remote and underserved areas. On-demand lab-in-a-box platforms enable point-of-care testing without centralized labs, improving turnaround times and clinical decision-making. This trend is reinforced by increasing chronic disease prevalence, aging populations, and the push for personalized medicine. Healthcare systems are adopting portable diagnostic solutions to reduce hospital burden and enhance care delivery in outpatient, homecare, and emergency settings.

Restraint:

High cost of compact analyzers

Despite their utility, compact analyzers used in lab-in-a-box systems remain expensive due to advanced microfluidic integration, proprietary reagents, and miniaturized hardware. These costs limit adoption in low-resource settings and small clinics. Additionally, maintenance, calibration, and consumables add to operational expenses. The lack of economies of scale and limited reimbursement frameworks further constrain market penetration. Price-sensitive buyers often delay procurement, awaiting cost-effective alternatives or subsidies, which slows overall market growth despite strong clinical demand.

Opportunity:

Integration with telehealth platforms

The convergence of lab-in-a-box diagnostics with telehealth platforms presents a transformative opportunity. Real-time data sharing, remote monitoring, and virtual consultations enhance diagnostic workflows and patient engagement. Integration enables clinicians to interpret results instantly and initiate treatment remotely, especially in rural or quarantined settings. This synergy supports chronic disease management, post-operative care, and infectious disease surveillance. As telemedicine adoption accelerates globally, embedded diagnostics within virtual care ecosystems will drive innovation and expand market reach.

Threat:

Stringent regulatory and accuracy standards

Lab-in-a-box solutions face stringent regulatory scrutiny due to their clinical impact. Ensuring analytical accuracy, reproducibility, and compliance with ISO and FDA standards is challenging, especially for multiplexed assays and novel platforms. Regulatory delays, complex approval pathways, and post-market surveillance requirements increase time-to-market and cost. Any deviation in performance can lead to recalls or litigation, damaging brand reputation. These hurdles deter new entrants and require substantial investment in validation, documentation, and quality assurance systems.

Covid-19 Impact:

COVID-19 significantly accelerated the adoption of point-of-care lab-in-a-box diagnostics, especially for rapid molecular and antigen testing. The pandemic highlighted the need for decentralized, scalable, and contactless diagnostic solutions. Governments and healthcare providers invested heavily in portable platforms to manage outbreaks and reduce lab overload. However, post-pandemic normalization has led to reduced emergency funding and shifting priorities. While demand remains strong for respiratory and infectious disease testing, vendors must pivot toward broader chronic and preventive applications.

The molecular diagnostics segment is expected to be the largest during the forecast period

The molecular diagnostics segment is expected to account for the largest market share during the forecast period, due to its high sensitivity, specificity, and versatility across infectious diseases, oncology, and genetic screening. Lab-in-a-box platforms increasingly incorporate PCR, isothermal amplification, and sequencing technologies for rapid pathogen detection and mutation analysis. The segment benefits from rising demand for early diagnosis, personalized medicine, and outbreak management. Its integration with digital health tools and miniaturized formats makes it ideal for point-of-care deployment, driving its market leadership.

The microfluidics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the microfluidics segment is predicted to witness the highest growth rate, driven by its ability to miniaturize complex lab processes into portable cartridges. These systems enable multiplexed assays, reduced reagent use, and faster turnaround times. Innovations in chip design, material science, and fluid control are expanding applications in hematology, immunoassays, and molecular diagnostics. As demand grows for compact, automated, and user-friendly platforms, microfluidics will underpin next-generation lab-in-a-box solutions, attracting investment and fueling rapid technological advancement.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to its vast population, rising healthcare expenditure, and growing demand for decentralized diagnostics. Countries like China, India, and Japan are investing in portable diagnostic infrastructure to address rural healthcare gaps and infectious disease burdens. Favorable government initiatives, expanding telemedicine networks, and local manufacturing capabilities support market growth. The region's diverse healthcare needs and rapid urbanization make it a prime target for lab-in-a-box deployment.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR fueled by advanced healthcare infrastructure, strong R&D investment, and early adoption of innovative diagnostics. The U.S. leads in telehealth integration, regulatory approvals, and reimbursement frameworks for point-of-care technologies. Growing demand for home-based testing, chronic disease management, and personalized care drives market expansion. Strategic partnerships, venture capital funding, and favorable policy support further accelerate growth, positioning North America as a key innovation hub for lab-in-a-box solutions.

Key players in the market

Some of the key players in On-Demand Point-of-Care Lab-in-a-Box Market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Becton Dickinson, Thermo Fisher Scientific, QuidelOrtho, PerkinElmer, Mesa Biotech, Cue Health, LumiraDx, Bio-Rad Laboratories, BioMerieux, Cardinal Health, Hologic, BD Veritor, and OraSure Technologies

Key Developments:

In Aug 2025, Siemens Healthineers & Cardinal Health announced a deepened partnership to deploy the "CLINITEST" lab-in-a-box systems across retail pharmacy clinics and urgent care centers in the U.S. The collaboration enhances supply chain logistics for test cartridges and includes a proprietary data analytics dashboard for population health trends.

In July 2025, Cue Health released its "Cue Pro" 2.0 system, featuring a new cartridge form factor for at-home monitoring of chronic inflammation markers (e.g., CRP) and vitamin D levels. The update includes enhanced Bluetooth connectivity with smart devices and a subscription service for personalized health insights and physician notifications.

In June 2025, Thermo Fisher Scientific enhanced its "Accelerate" Arc system with GPU-accelerated data analysis for its antimicrobial susceptibility testing (AST) module. The update supports faster identification of resistant pathogens and optimal antibiotic recommendations directly at the point of care, aiding in the fight against antimicrobial resistance (AMR).

Test Types Covered:

  • Molecular Diagnostics
  • Immunoassay Testing
  • Hematology
  • Chemistry Panels
  • Microbiology & Pathogen Detection
  • Genomic & Proteomic Tests

Technologies Covered:

  • Microfluidics
  • Lab-on-Chip
  • AI-Powered Diagnostics
  • Portable PCR Systems
  • Biosensor-Based Detection
  • Cloud-Connected Analysis

Applications Covered:

  • Infectious Disease Testing
  • Chronic Disease Management
  • Drug Screening
  • Genetic Testing
  • Cancer Detection
  • Wellness & Preventive Care

End Users Covered:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Home Healthcare Providers
  • Diagnostic Laboratories
  • Military & Field Units
  • Research Institutions

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global On-Demand Point-of-Care Lab-in-a-Box Market, By Test Type

  • 5.1 Introduction
  • 5.2 Molecular Diagnostics
  • 5.3 Immunoassay Testing
  • 5.4 Hematology
  • 5.5 Chemistry Panels
  • 5.6 Microbiology & Pathogen Detection
  • 5.7 Genomic & Proteomic Tests

6 Global On-Demand Point-of-Care Lab-in-a-Box Market, By Technology

  • 6.1 Introduction
  • 6.2 Microfluidics
  • 6.3 Lab-on-Chip
  • 6.4 AI-Powered Diagnostics
  • 6.5 Portable PCR Systems
  • 6.6 Biosensor-Based Detection
  • 6.7 Cloud-Connected Analysis

7 Global On-Demand Point-of-Care Lab-in-a-Box Market, By Application

  • 7.1 Introduction
  • 7.2 Infectious Disease Testing
  • 7.3 Chronic Disease Management
  • 7.4 Drug Screening
  • 7.5 Genetic Testing
  • 7.6 Cancer Detection
  • 7.7 Wellness & Preventive Care

8 Global On-Demand Point-of-Care Lab-in-a-Box Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals & Clinics
  • 8.3 Ambulatory Care Centers
  • 8.4 Home Healthcare Providers
  • 8.5 Diagnostic Laboratories
  • 8.6 Military & Field Units
  • 8.7 Research Institutions

9 Global On-Demand Point-of-Care Lab-in-a-Box Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Laboratories
  • 11.2 Roche Diagnostics
  • 11.3 Siemens Healthineers
  • 11.4 Danaher Corporation
  • 11.5 Becton Dickinson
  • 11.6 Thermo Fisher Scientific
  • 11.7 QuidelOrtho
  • 11.8 PerkinElmer
  • 11.9 Mesa Biotech
  • 11.10 Cue Health
  • 11.11 LumiraDx
  • 11.12 Bio-Rad Laboratories
  • 11.13 BioMerieux
  • 11.14 Cardinal Health
  • 11.15 Hologic
  • 11.16 BD Veritor
  • 11.17 OraSure Technologies

List of Tables

  • Table 1 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Test Type (2024-2032) ($MN)
  • Table 3 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Molecular Diagnostics (2024-2032) ($MN)
  • Table 4 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Immunoassay Testing (2024-2032) ($MN)
  • Table 5 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Hematology (2024-2032) ($MN)
  • Table 6 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Chemistry Panels (2024-2032) ($MN)
  • Table 7 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Microbiology & Pathogen Detection (2024-2032) ($MN)
  • Table 8 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Genomic & Proteomic Tests (2024-2032) ($MN)
  • Table 9 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Technology (2024-2032) ($MN)
  • Table 10 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Microfluidics (2024-2032) ($MN)
  • Table 11 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Lab-on-Chip (2024-2032) ($MN)
  • Table 12 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By AI-Powered Diagnostics (2024-2032) ($MN)
  • Table 13 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Portable PCR Systems (2024-2032) ($MN)
  • Table 14 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Biosensor-Based Detection (2024-2032) ($MN)
  • Table 15 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Cloud-Connected Analysis (2024-2032) ($MN)
  • Table 16 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Infectious Disease Testing (2024-2032) ($MN)
  • Table 18 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Chronic Disease Management (2024-2032) ($MN)
  • Table 19 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Drug Screening (2024-2032) ($MN)
  • Table 20 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Genetic Testing (2024-2032) ($MN)
  • Table 21 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Cancer Detection (2024-2032) ($MN)
  • Table 22 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Wellness & Preventive Care (2024-2032) ($MN)
  • Table 23 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By End User (2024-2032) ($MN)
  • Table 24 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 25 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Ambulatory Care Centers (2024-2032) ($MN)
  • Table 26 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Home Healthcare Providers (2024-2032) ($MN)
  • Table 27 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 28 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Military & Field Units (2024-2032) ($MN)
  • Table 29 Global On-Demand Point-of-Care Lab-in-a-Box Market Outlook, By Research Institutions (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.